Zobrazeno 1 - 4
of 4
pro vyhledávání: '"S. T. Lillevang"'
Autor:
M. N. Olesen, K. Soelberg, B. Debrabant, A. C. Nilsson, S. T. Lillevang, J. Grauslund, I. Brandslund, J. S. Madsen, F. Paul, T. J. Smith, S. Jarius, N. Asgari
Publikováno v:
Journal of Neuroinflammation, Vol 16, Iss 1, Pp 1-12 (2019)
Abstract Background Long-term outcome in multiple sclerosis (MS) depends on early treatment. In patients with acute optic neuritis (ON), an early inflammatory event, we investigated markers in cerebrospinal fluid (CSF), which may predict a diagnosis
Externí odkaz:
https://doaj.org/article/e2be5c0a4fdc42e78e1de38391cbeb9d
Autor:
S T, Lillevang, N, Morling
Publikováno v:
Ugeskrift for laeger. 159(27)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::527d07d8e5159e4aec34686be0d4b127
https://pubmed.ncbi.nlm.nih.gov/9229886
https://pubmed.ncbi.nlm.nih.gov/9229886
Autor:
S T, Lillevang, T, Kristensen
Publikováno v:
Ugeskrift for laeger. 154(43)
Transfusion-associated graft-versus-host disease (TA-GVHD) is a serious, often fatal complication to the transfusion of blood components. TA-GVHD is caused primarily by donor T lymphocytes reacting towards recipient MHC antigens. The diagnosis TA-GVH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5d04171e7a8c3d533f86e3ce6038a402
https://pubmed.ncbi.nlm.nih.gov/1462384
https://pubmed.ncbi.nlm.nih.gov/1462384
Autor:
S T, Lillevang, F B, Pedersen
Publikováno v:
Ugeskrift for laeger. 152(41)
In a double-blind, placebo-controlled trial of rHu-EPO (recombinant human erythropoietin) comprizing 19 haemodialysis patients (rHu-EPO: n = 9, placebo: n = 10) the patients' opinion about the influence of the treatment on the quality of life was inv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ba9292af18f33a83a11e70e37c02f120
https://pubmed.ncbi.nlm.nih.gov/2238169
https://pubmed.ncbi.nlm.nih.gov/2238169